Identifying Metabolic Risks With Antipsychotics and Monitoring and Management Strategies
J Clin Psychiatry 2007;68(7):e17
© Copyright 2014 Physicians Postgraduate Press, Inc.
Access to this article is available to valid users
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Register: If you do not have one already, register for a free account.
Mental health providers have an especially important responsibility to monitor the
physical changes that patients have in response to medication. The current
public health focus is on adiposity as a major risk factor for diabetes,
coronary heart disease, insulin resistance syndrome, metabolic syndrome, and
other diseases. Adiposity has an adverse effect on insulin action, which can lead to a cycle in which insulin loses its
ability to stop the breakdown of fat. Because type 2 diabetes takes approximately
2 decades to develop, patients with increased BMI can be at risk for adverse
effects to their physical health for many years. Because of the possibility that some
antipsychotic treatments can lead to weight gain and metabolic changes and
possibly to severe physical illness, regular physical checks should be made.
This expired activity is not currently available online. Please send us an email to request it. Activities with user requests will receive priority as we make more expired activities available.